Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arch Therapeutics Inc ARTH

Consumer Cyclical Healthcare Medical Instruments & Supplies
Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These... see more

Recent & Breaking News (OTCQB:ARTH)

Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)

GlobeNewswire May 6, 2024

Arch Therapeutics Provides Year End Operational Update

GlobeNewswire November 9, 2023

Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)

GlobeNewswire November 2, 2023

Arch Therapeutics Provides AC5® Commercialization Update

GlobeNewswire September 13, 2023

Arch Therapeutics Completes Financing as Bridge to Uplisting

GlobeNewswire September 7, 2023

Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care ("SAWC")

GlobeNewswire April 25, 2023

Dedicated HCPCS Billing Code for Arch Therapeutics' AC5® Advanced Wound System Now In Effect

GlobeNewswire April 5, 2023

Arch Therapeutics' AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid Services

GlobeNewswire March 9, 2023

Arch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government Facilities

GlobeNewswire March 7, 2023

Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System

GlobeNewswire January 18, 2023

Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National Exchange

GlobeNewswire January 17, 2023

The Centers for Medicare & Medicaid Services Makes Preliminary Recommendation to Establish New HCPCS Billing Code Dedicated to Arch Therapeutics' AC5® Advanced Wound System

GlobeNewswire December 5, 2022

Key Opinion Leaders Presented Arch Therapeutics' AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Fall

GlobeNewswire October 18, 2022

Arch Therapeutics' AC5® Advanced Wound System to be Presented with Honors at 2022 Symposium on Advanced Wound Care (SAWC) Fall

GlobeNewswire October 11, 2022

Arch Therapeutics Announces First Shipments of AC5® Advanced Wound System Under New Reimbursement Support Program

GlobeNewswire September 23, 2022

Arch Therapeutics Accepted to Present AC5® Advanced Wound System During Innovation Spotlight at 2022 Symposium on Advanced Wound Care (SAWC)

GlobeNewswire September 20, 2022

Arch Therapeutics Announces Intent to Uplist from OTC to a National Exchange

GlobeNewswire September 16, 2022

Arch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound System

GlobeNewswire September 7, 2022

Arch Therapeutics Submits Application to Centers for Medicare and Medicaid Services for AC5® Advanced Wound System

GlobeNewswire September 1, 2022

Arch Therapeutics Raises Approximately $3.5 Million in Convertible Note Financing

GlobeNewswire July 7, 2022